Anesthetics Flashcards
(82 cards)
types of general anasthesia
(a) monitored anesthesia care techniques = local anesthetic and sedatives, patient can still respond to verbal commands
(b) balanced anesthesia = iv anesthetic + inhaled anesthetic
intravenous anesthetics
(a) barbiturates (thiopental, methohexital)
(b) benzodiazepams (midazolam, diazepam)
(c) propofol
(d) ketamine
(e) opioid analgesics (morphine, fentanyl, sufentanil, alfentanil, remifentanil)
(f) misc sedative hypnotics (etomidate, dexmedetomidine)
inhaled anesthetics
(a) halothane, enflurane, isoflurane, desflurane, sevoflurane = volatile anesthetics, liquids at room temp
(b) nitrous oxide, xenon = gaseous anesthetics, gas at room temp
balanced anesthesia
(a) iv for induction
(b) inhaled for maintenance of anesthesia
**stages of anesthesia - inhaled anasthetics
(a) Stage I Analgesia, initially analgesia without amnesia
(b) Stage II Excitement, delirious and vocalizing but amnesic
**goal of all anesthesia is to get you through stage II as fast and safely as possible
(c) Stage III Surgical Anesthesia, pupil size used to determine plane of this stage
(d) Stage IV Medullary Depression, CNS depression, death ensues
(e) The most reliable indication of Stage III Surgical Anesthesia is loss of response to noxious stimuli (trapezius muscle squeeze) and reestablishment of regular respiratory pattern
GOAL IS TO GET TO 3 SAFELY AND STAY THERE! DONT GO TO 4 or you die
concentration of inhaled anesthetic gas is proportional to what?
the partial pressure (also called tension) of that gas
factors that control movement of gas into the CNS (time to induction) - inhaled anasthetics
- solubility
- concentration in inspired air
- pulmonary ventilation
- pulmonary blood flow
- arteriovenous concentration gradient
- if the gas is highly soluble, it will want to stay in the blood and enter the brain - slow induction - slow onset
- if the gas is poorly soluble, it doesnt like the blood, prefers the fat of the brain - fast induction - fast onset - the higher the solubility, the less amount of gas is needed to induce anesthesia (this is good!) - eliminated from blood faster
movement of gas into CNS: solubility - inhaled anasthetics
(a) blood:gas partition coefficient
(b) solubility of gas in inspired gas vs blood
(c) nitrous oxide has low solubility in blood, has rapid onset of action (moves into the brain rapidly)
(d) Table 25-1 pg 425 for list of inhaled anesthetics and blood:gas partition ratio
(e) nitrous oxide 0.47 vs methoxyflurane 12 (rapid to slow induction) based on blood solubility
movement of gas into CNS: concentration in inspired air - inhaled anasthetics
(a) enflurane, isoflurane, halothane have moderate blood solubility
(b) increase the concentration in inspired air to 1.5% to increase blood levels and entry into brain, then reduce to 0.7% for maintenance
movement of gas into CNS: pulmonary ventilation - inhaled anasthetics
(a) minute ventilation = rate and depth of ventilation
(b) fourfold increase in ventilation rate almost doubles the arterial tension of halothane
(c) hyperventilation increases the speed of induction of anesthesia
(d) depression of respiration by opioid analgesics slows the
onset of anesthesia
movement of gas into CNS: pulmonary blood flow - inhaled anasthetics
(a) increased blood flow through the lung exposes the anesthetic to larger volumes of blood in the alveoli which reduces
(b) increased exposure to blood, increased solubility in blood, decreased transfer into the brain
movement of gas into CNS: arteriovenous concentration gradient - inhaled anasthetics
(a) arterial: venous blood gradient
(b) venous blood returning to the lung has less anesthetic due to drug taken up into tissues
(c) this will decrease drug entry into the brain
elimination of inhaled anasthetics
- ***(a) most important factor is blood gas partition coefficient
- poorly soluble, low gas partition, eliminated faster
(b) gas has to leave the brain, enter the blood, then be exhaled
(c) gas insoluble in blood (low blood:gas partition coefficient) is eliminated faster than more soluble gas anesthetics
(d) halothane is twice as soluble in brain compared to nitrous oxide and takes longer to be eliminated compared to nitrous oxide
(e) clearance of inhaled anesthetics via the lungs is the major route of elimination from the body
(f) liver biotransformation may contribute to elimination for some inhaled anesthetics, halothane is 40% botransformed by liver, compared to < 10% for enflurane
(g) liver biotranformation of fluoride containing inhaled anesthetics can lead to the production of chlorotrfluoroethyl free radicals which can produce an halothane hepatitis
(h) liver biotransformation of enflurane and sevoflurane can produce fluoride ions which produce kidney dmage, more pronounced with methoxyflurane (rarely used for this reason)
(j) sevoflurane is degraded by the carbon dioxide absorbent in anesthesia machines producing a vinyl ether which can cause kidney damage.
**MOA - inhaled anasthetics
(a) primary target is the GABA chloride channel
(b) inhaled anesthetics, barbiturates, benzodiazepines, etomidate, propofol all enhance GABA mediated inhibition
(c) ketamine, a dissociate anesthetic is an antagonist at NMDA glutamic acid excitatory channels.
(d) inhaled anesthetics may also act through hyperpolairzation of neurons through activation of potassium channels
(e) inhaled anesthetics may also block the excitatory actions of Ach at nicotinic receptors and their cation channel receptors
dose-response characteristics: Minimal Alveolar Anesthetic Concentration - inhaled anasthetics
MAC IS MEASURE OF POTENTCY
(a) dose-response relationships for the inhaled anesthetics are unique and have ethical considerations. Low doses allow pain, higher dose can allow pain and higher doses can induce death.
(b) at steady state the concentration (partial pressure) of the inhaled anesthetic in brain = concentration (partial pressure) in the lung
(c) anesthic can not be measured in the brain but can be measured in the alvelor air (lung air)
(d) concentration in the alvelor air is reported as the % of 760 mm Hg (atmospheric pressure at sea level)
(e) MAC = minimum alveolar anesthetic
(f) MAC = concentration that results in immobility in 50% of patients when exposed to noxius stimulus (surgical anesthesia)
(g) MAC = surrogate measure of the anesthetic requirement
(h) MAC = measure of anesthetic potency among the different gases
(i) MAC for nitrous oxide > 100%, the least potent
(j) MAC for enflurane is 1.7 %, more potent
(k) MAC dosing, a dose of 1 MAC will produce surgical anesthesia in 50% ofpatients
(l) MAC decreased with coadministered drugs, opioids, sympatholytics, sedative-hypnotics
* 0.5 MAC is mild amnesia, 99% pts immobilized at a 1.3 MAC
Effects on CV system - inhaled anasthetics
(a) decrease arterial bp in direct proportion to their alveolar concentration
(halothane, desflurane, enflurane, sevoflurane, isoflrane)
(b) mechanism varies, halothane and enflurane decrease cardiac output; iso-flurane, desflurane, sevoflurane decrease peripheral vascular resitance
(c) heart rate, halothane causes bradycardia through direct vagal stimulation, enflurane, sevoflurane no effect, desflurane and isoflurane increase heartrate.
(d) beta blockers used to treat increased catecholamine stimulated increase in blood pressure
effect on respiratory system - inhaled anasthetics
(a) all (except nitrous oxide) produce a decrease in tidal volume and an increase
in respiratory rate
(b) all volatile anesthetics are respiratory depressants
(c) all volatile anesthetics increase the pACO2
(d) all volatile anesthetics depress mucociliary function (mucous pooling,
atelectasis, postoperative lung infection)
(e) halothane and sevoflurane have bronchodilating actions which them drugs of choice in patients with asthma, bronchitis, COPD)
effect on brain - inhaled anasthetics
(a) all decrease the metabolic rate of the brain
(b) all increase cerebral blood flow, not desired in patients with increased
intracranial brain pressure due to tumor, or head injury
(c) nitrous oxide less likely to increase cerebral blood flow
effect on kidney - inhaled anasthetics
(a) decrease the glomerular filtration
effect on liver - inhaled anasthetics
(a) from 15-45% decrease hepatic blood flow
liver toxicity - inhaled anasthetics
(1) halothane hepatitis (prior exposure required)
(2) incidence 1 in 25 000 – 35 000
(3) halothane may induce immune mediate cause
kidney toxicity - inhaled anasthetics
(1) methoxyflurane, enflurane, sevoflurane are biotransformed and release fluoride ions that can lead to toxicity
(2) sevoflurane is degraded by carbon dioxide absorbents in anesthesia machines leads to a toxic compound which causes proximal tubular necrosis
(3) methoxyflurane no longer used due to potential for renal toxicity
malignant hyperthermia - inhaled anasthetics
(a) caused by a genetic disorder of skeletal muscle
(b) condition induced by general anesthetics and succinylcholine (skeletal muscle relanxant)
(c) condition presents with tachycardia, hypertension, muscle rigidity, hyperthermia, hyperkalemia, acidosis.
(d) triggering agents Table 16-4 pg 283
(e) cause is uncontrolled release of calcium from SR in muscle
(f) treat with dantrolene which blocks the release of Ca from SR
(g) skeletal muscle biopsy and caffeine-halothane contracture test required to screen for malignant hyperthermia
chronic toxicity - inhaled anesthetics
(a) Mutagenicity (1) no effect demonstrated
(b) Carcinogenicity (1) no effect demonstrated
(c) Reproductive Organs (1) higher incidence of miscarriages among OR personnel